ArticleJACC. Advances2026
Clinical and Echocardiographic Factors Associated With Left Ventricular Thrombus Recurrence.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeft ventricular (LV) thrombus (LVT) recurrence risk influences decision-making regarding oral anticoagulation (OAC) duration.
objectivesThe aim of the study was to evaluate risk of LVT recurrence and factors associated with recurrence.
methodsThis was a multicenter, retrospective cohort of patients with resolved LVT, diagnosed by echocardiography. Clinical and echocardiographic characteristics at LVT diagnosis and resolution were evaluated for association with recurrence. Multivariable Cox proportional hazards regression was used to identify determinants of LVT recurrence.
resultsAmong 252 patients (mean age 64.5 years, 78.6% male), LVT recurred in 36 (14.3%). Although LV systolic function at the time of presentation was similar between those with and without recurrence, patients who developed recurrent LVT had lower LV ejection fraction (LVEF) (34.0% vs 40.0%; P = 0.04) and more frequently had LV apical aneurysm (25.0% vs 6.5%; P = 0.001) at LVT resolution. Continuing OAC after LVT resolution was associated with less recurrence (54.7% vs 25.0%; P = 0.005). In multivariable analysis, LV apical aneurysm (HR: 3.12; 95% CI: 1.43 to 6.84) and previous ischemic stroke (HR: 2.75; 95% CI: 1.22-6.17) were associated with higher rates of recurrence, whereas higher LVEF (HR: 0.96 per 1% increase; 95% CI: 0.95-0.99) and OAC continuation (HR: 0.27; 95% CI: 0.13-0.58) were associated with decreased recurrence.
conclusionsIn this population, LVT recurred in 14% of patients and was associated with LV apical aneurysm and prior stroke, whereas lower rates of recurrence were associated with higher LVEF and continuation of OAC. Echocardiographic characteristics at the time of LVT resolution were associated with LVT recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.